: DNA content analysis by flow cytometry of Cell cycle fractions from asynchronously growing (Async), thymidine synchronised G1 and G2 phase cells, nocodazole arrested mitotic cells (M), and UV-G2 checkpoint arrested cells. The cells were from the melanoma cell lines A2058 and MM576. Figure S2 : Immunoblots of cell cycle fractions for the indicated proteins from the same samples as analysed in Supplementary Figure S1 . PCNA is a loading control. Figure S3 : A. Cell counts for untransfected (cells only) and cells transfected with nontargeting (NT) or positive control PLK1 siRNAs for both A2058 and MM576 cells. Three time points were assessed, mock irradiated and irradiated with UVR then allowed to recover for 24 and 40 h. The data are mean and SD from six replicates. B. Viability of the same experiment A was measured by resazurin assay. The data are expressed a percentage of the untransfected, mock irradiated cells. C. Timeline of the siRNA experiment. The arrowheads indicate where the cells were fixed for analysis. Figure S4 : A2058 cells, either control or 24 h after UVR were immunostained for RPA2 and DNA. RPA foci are detected in the UVR treated cells. A2058 and MM576 cells, untransfected, non-targeting (NT) and PLK1 siRNA transfection controls, and transfected with siRNAs targeting UV-G2 checkpoint candidate genes. Three timepoints were assessed, mock irradiated controls, and cells fixed 24 and 40 h after UVR. The blue line is the number cell in the MM576 control (M) and the black line is the control for the A2058 (A). Figure 6A , and the mitotic marker pH3 was used to assess progression into mitosis. This is representative of two separate experiments.
Figure S15: Genetic defect and mRNA expression level analysis of the indicated genes (PPP2R2A synonym for B55) from the TCGA Skin Cutaneous Melanoma data set. For expression level a z-score of 3 was used as the cut-off. 
